Table 2.
Metabolites associated with intervention from linear model (named/annotated representative features only)
| Biochemical name | Super pathway | Sub-pathway | Source | β | Lower 95% CI |
Upper 95% CI |
Holm-corrected p value |
|---|---|---|---|---|---|---|---|
| Erythronatea | Carbohydrate | Aminosugar metabolism | Metabolon | −0.82 | −0.99 | −0.65 | 2.84×10−15 |
| N-Lactoyl isoleucine | Amino acid | Leucine, isoleucine and valine metabolism | Metabolon | −0.87 | −1.08 | −0.66 | 5.96×10−11 |
| 1-(1-Enyl-palmitoyl)−2-oleoyl-GPC (P−16:0/18:1)a | Lipid | Plasmalogen | Metabolon | 0.59 | 0.43 | 0.74 | 2.28×10−9 |
| β-Alanine | Nucleotide | Pyrimidine metabolism, uracil containing | Metabolon | −0.68 | −0.87 | −0.49 | 9.86×10−9 |
| Glucose | Carbohydrate | Glycolysis, gluconeogenesis and pyruvate metabolism | Metabolon | −0.75 | −0.95 | −0.54 | 2.13×10−8 |
| 1-Stearoyl−2-oleoyl-GPE (18:0/18:1) | Lipid | Phosphatidylethanolamine | Metabolon | −0.67 | −0.86 | −0.48 | 3.26×10−8 |
| Glycosyl ceramide (d18:2/24:1, d18:1/24:2)a | Lipid | Hexosylceramides | Metabolon | 0.64 | 0.46 | 0.82 | 5.16×10−8 |
| Hydroxy-CMPFa | Lipid | Fatty acid, dicarboxylate | Metabolon | 0.35 | 0.24 | 0.45 | 2.60×10−7 |
| Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2)a | Lipid | Sphingomyelins | Metabolon | 0.54 | 0.38 | 0.70 | 3.59×10−7 |
| Isoleucine | Amino Acid | NA | Nightingale | −0.62 | −0.82 | −0.41 | 2.66×10−6 |
| Betaine | Amino Acid | Glycine, serine and threonine metabolism | Metabolon | 0.52 | 0.35 | 0.68 | 4.36×10−6 |
| 4-Ethylphenylsulfate | Xenobiotics | Benzoate metabolism | Metabolon | 0.65 | 0.43 | 0.86 | 1.07×10−5 |
| Alanine | Amino Acid | Alanine and aspartate metabolism | Metabolon | −0.63 | −0.83 | −0.42 | 1.14×10−5 |
| Palmitoylcholine | Lipid | Fatty acid metabolism (acyl choline) | Metabolon | 0.66 | 0.43 | 0.88 | 2.94×10−5 |
| 6-Bromotryptophan | Amino Acid | Tryptophan metabolism | Metabolon | 0.57 | 0.37 | 0.77 | 6.49×10−5 |
| 3β,7α-Dihydroxy−5-cholestenoate | Lipid | Sterol | Metabolon | −0.41 | −0.55 | −0.26 | 1.12×10−4 |
| 4-Hydroxychlorothalonil | Xenobiotics | Chemical | Metabolon | 0.36 | 0.23 | 0.50 | 2.84×10−4 |
| Palmitoyl sphingomyelin (d18:1/16:0) | Lipid | Sphingomyelins | Metabolon | 0.49 | 0.30 | 0.67 | 3.35×10−4 |
| Cholesterol esters to total lipids ratio in medium VLDL | NMR ratio/percentage | NA | Nightingale | 0.49 | 0.29 | 0.69 | 4.76×10−4 |
| N-Acetylmethionine | Amino acid | Methionine, cysteine, SAM and taurine metabolism | Metabolon | 0.51 | 0.31 | 0.71 | 7.35×10−4 |
| Bilirubin (Z,Z) | Cofactors and vitamins | Haemoglobin and porphyrin metabolism | Metabolon | 0.48 | 0.29 | 0.67 | 7.98×10−4 |
| Arachidonoylcarnitine (C20:4) | Lipid | Fatty acid metabolism (acyl carnitine) | Metabolon | 0.46 | 0.28 | 0.64 | 9.66×10−4 |
| Tryptophan betaine | Amino acid | Tryptophan metabolism | Metabolon | 0.49 | 0.29 | 0.68 | 1.70×10−3 |
| 3-Methyl−2-oxovalerate | Amino acid | Leucine, isoleucine and valine metabolism | Metabolon | −0.47 | −0.66 | −0.28 | 1.91×10−3 |
| TGs in small HDL | Lipid | NA | Nightingale | −0.43 | −0.62 | −0.24 | 2.18×10−3 |
| 1-Arachidonoyl-GPC (20:4n6)a | Lipid | Lysophospholipid | Metabolon | 0.46 | 0.27 | 0.64 | 2.22×10−3 |
| Total cholesterol in very large HDL | Lipid | NA | Nightingale | 0.39 | 0.22 | 0.56 | 2.46×10−3 |
| α-Hydroxycaproate | Lipid | Fatty acid, monohydroxy | Metabolon | −0.62 | −0.87 | −0.37 | 2.47×10−3 |
| Sphingomyelin (d17:1/14:0, d16:1/15:0)a | Lipid | Sphingomyelins | Metabolon | 0.38 | 0.23 | 0.54 | 2.57×10−3 |
| 1-Stearoyl-GPC (18:0) | Lipid | Lysophospholipid | Metabolon | 0.50 | 0.30 | 0.71 | 2.70×10−3 |
| Total cholesterol to total lipids ratio in small LDL | NMR ratio/percentage | NA | Nightingale | 0.44 | 0.24 | 0.63 | 4.08×10−3 |
| 3-Hydroxyoctanoate | Lipid | Fatty acid, monohydroxy | Metabolon | −0.52 | −0.73 | −0.30 | 5.14×10−3 |
| Non-esterified cholesterol in small HDL | Lipid | NA | Nightingale | −0.40 | −0.59 | −0.22 | 5.24×10−3 |
| Carnitine | Lipid | Carnitine metabolism | Metabolon | 0.40 | 0.23 | 0.57 | 5.67×10−3 |
| 2-Docosahexaenoylglycerol (22:6)a | Lipid | Monoacylglycerol | Metabolon | 0.55 | 0.32 | 0.79 | 6.05×10−3 |
| γ-Glutamylglutamine | Peptide | γ-Glutamyl amino acid | Metabolon | 0.45 | 0.25 | 0.64 | 8.94×10−3 |
| Histidine | Amino acid | Histidine metabolism | Metabolon | 0.50 | 0.28 | 0.72 | 1.07×10−2 |
| Ornithine | Amino acid | Urea cycle; arginine and proline metabolism | Metabolon | 0.45 | 0.25 | 0.65 | 1.24×10−2 |
| 2-Hydroxybutyrate/2-hydroxyisobutyrate | Amino acid | Glutathione metabolism | Metabolon | −0.49 | −0.70 | −0.27 | 1.40×10−2 |
| 1-Palmitoyl−2-arachidonoyl-GPE (16:0/20:4)a | Lipid | Phosphatidylethanolamine | Metabolon | −0.40 | −0.58 | −0.22 | 1.45×10−2 |
| Glycerol | Lipid | NA | Nightingale | −0.48 | −0.71 | −0.24 | 1.57×10−2 |
| n−3 Fatty acids | Lipid | NA | Nightingale | 0.34 | 0.17 | 0.50 | 1.71×10−2 |
| Aconitate (cis or trans) | Energy | TCA cycle | Metabolon | −0.45 | −0.65 | −0.25 | 2.01×10−2 |
| 5-Methylthioadenosine | Amino acid | Polyamine metabolism | Metabolon | −0.48 | −0.69 | −0.26 | 2.06×10−2 |
| 5α-Androstan−3β,17β-diol monosulfate (2) | Lipid | Androgenic steroids | Metabolon | −0.38 | −0.55 | −0.21 | 2.48×10−2 |
| Cholesteryl esters in large HDL | Lipid | NA | Nightingale | 0.32 | 0.16 | 0.49 | 2.52×10−2 |
| Glycoprotein acetyls, mainly a1-acid glycoprotein | Peptide | NA | Nightingale | −0.32 | −0.49 | −0.16 | 2.57×10−2 |
| Taurine | Amino acid | Methionine, cysteine, SAM and taurine metabolism | Metabolon | 0.45 | 0.24 | 0.66 | 2.83×10−2 |
| Glycine | Amino acid | Glycine, serine and threonine metabolism | Metabolon | 0.40 | 0.22 | 0.59 | 3.07×10−2 |
| Oxalate (ethanedioate) | Cofactors and vitamins | Ascorbate and aldarate metabolism | Metabolon | 0.40 | 0.21 | 0.58 | 4.69×10−2 |
Effect estimates (β) shown for the fixed effect ‘allocation’ where control group is considered the reference group with effect estimates, therefore representing the difference seen in the intervention group relative to the control group (in normalised SD units). For additional metadata see ESM Tables 2, 3, 6
aCompound has not been confirmed based on a standard
CMPF, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid; GPC, glycerophosphocholine; GPE, glycerophosphoethanolamine; NA, not applicable; SAM, S-adenosylmethionine